SERPINF2 and pulmonary embolism: More recently, Singh and colleagues used a humanised α2AP mouse model of pulmonary embolism to investigate the effects of pharmacological recombinant tPA (r-tPA) and α2AP inhibition on fibrinolysis and bleeding [151].